NCT05733312 2026-01-30Extracellular Impact of Ultrasound-induced Blood-brain Barrier DisruptionMayo ClinicPhase NA Recruiting6 enrolled
NCT00431561 2013-12-03Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade GliomaIsarna Therapeutics GmbHPhase 2 Completed141 enrolled